Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study

Methotrexate (MTX) is a systemic immunosuppressant drug used for the treatment of psoriasis and psoriatic arthritis. Previous studies demonstrated a potential association between psoriasis and diabetes mellitus, obesity, atherosclerosis, hypertension, eventuating into metabolic syndrome. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Dehpouri, Tannaz, Rokni, Ghasem Rahmatpour, Narenjbon, Nematollah Ahangar, Goldust, Mohamad, Yamauchi, Paul S., Wollina, Uwe, Lotti, Torello, Kircik, Leon, Lernia, Vito Giuseppe Di, Sonthalia, Sidharth, Vojvodic, Aleksandra, Szepietowski, Jacek, Bahadoran, Philippe, Errichetti, Enzo, Cantisani, Carmen, Atzori, Laura, Rezaee, Elham, Kutlubay, Zekayi, Engin, Burhan, Nisticò, Steven, Damiani, Giovanni, Conic, Rosalynn R.Z., Goren, Andy, Čabrijan, Leo, Tchernev, Georgi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547029/
https://www.ncbi.nlm.nih.gov/pubmed/31210916
http://dx.doi.org/10.4081/dr.2019.7965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547029/
https://www.ncbi.nlm.nih.gov/pubmed/31210916
http://dx.doi.org/10.4081/dr.2019.7965

Ejemplares similares